Killer lymphocytes: referred to as K cells, are differentiated and developed from lymphoid stem cells in the bone marrow. They account for 5% to 7% of the total number of lymphocytes in the blood. They are smaller than T and B lymphocytes and are slightly larger in size. , are medium-sized lymphocytes with a diameter of about 9 to 12 μm. There are lysosomes and secretory granules in the cytoplasm. There are Fc receptors (antibody receptors) on the K cell membrane. When the antibody binds to the target cell (antigen), K cells use Fc receptors to bind to the Fc end of specific antibodies, causing the target cells to quickly lose activity and kill the target cells. K cells must be assisted by antibodies to have immune killing effects, so K cells are also called antibody-dependent Antibody dependent cell-mediated cytotoxic cell (ADCC), K cells mainly attack target cells that are larger than microorganisms, which can be virus-infected cells, such as liver cells in chronic active hepatitis. Due to the large size of these cells, It is difficult to be phagocytized. K cells have an extracellular killing effect. They can clear them and have a clear killing effect on tumor cells. The increase in K cells in the peripheral blood of allogeneic transplant patients shows that K cells are also involved in rejection reactions.

The global K Cells market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for K Cells is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for K Cells is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of K Cells include Chipscreen Biosciences, Affimed NV, Altor BioScience, Innate Pharma, Takeda, Sorrento Therapeutics, NantKwest, Bristol-Myers Squibb and NKT, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for K Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding K Cells.

Report Scope

The K Cells market size, estimations, and forecasts are provided in terms of sales volume (g) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global K Cells market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the K Cells manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of K Cells Market Report

Report Metric	Details
Report Name	K Cells Market
Segment by Type	Mogamulizumab Lorvotuzumab Mertansine Others
Segment by Application	Cancer Cardiovascular Diseases Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Chipscreen Biosciences, Affimed NV, Altor BioScience, Innate Pharma, Takeda, Sorrento Therapeutics, NantKwest, Bristol-Myers Squibb, NKT, Henry Ford Health Services
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of K Cells manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of K Cells in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the K Cells Market report?

Ans: The main players in the K Cells Market are Chipscreen Biosciences, Affimed NV, Altor BioScience, Innate Pharma, Takeda, Sorrento Therapeutics, NantKwest, Bristol-Myers Squibb, NKT, Henry Ford Health Services

What are the Application segmentation covered in the K Cells Market report?

Ans: The Applications covered in the K Cells Market report are Cancer, Cardiovascular Diseases, Others

What are the Type segmentation covered in the K Cells Market report?

Ans: The Types covered in the K Cells Market report are Mogamulizumab, Lorvotuzumab Mertansine, Others

1 K Cells Market Overview

1.1 Product Overview and Scope of K Cells

1.2 K Cells Segment by Type

1.2.1 Global K Cells Market Value Comparison by Type (2024-2030)

1.2.2 Mogamulizumab

1.2.3 Lorvotuzumab Mertansine

1.2.4 Others

1.3 K Cells Segment by Application

1.3.1 Global K Cells Market Value by Application: (2024-2030)

1.3.2 Cancer

1.3.3 Cardiovascular Diseases

1.3.4 Others

1.4 Global K Cells Market Size Estimates and Forecasts

1.4.1 Global K Cells Revenue 2019-2030

1.4.2 Global K Cells Sales 2019-2030

1.4.3 Global K Cells Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 K Cells Market Competition by Manufacturers

2.1 Global K Cells Sales Market Share by Manufacturers (2019-2024)

2.2 Global K Cells Revenue Market Share by Manufacturers (2019-2024)

2.3 Global K Cells Average Price by Manufacturers (2019-2024)

2.4 Global K Cells Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of K Cells, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of K Cells, Product Type & Application

2.7 K Cells Market Competitive Situation and Trends

2.7.1 K Cells Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest K Cells Players Market Share by Revenue

2.7.3 Global K Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 K Cells Retrospective Market Scenario by Region

3.1 Global K Cells Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global K Cells Global K Cells Sales by Region: 2019-2030

3.2.1 Global K Cells Sales by Region: 2019-2024

3.2.2 Global K Cells Sales by Region: 2025-2030

3.3 Global K Cells Global K Cells Revenue by Region: 2019-2030

3.3.1 Global K Cells Revenue by Region: 2019-2024

3.3.2 Global K Cells Revenue by Region: 2025-2030

3.4 North America K Cells Market Facts & Figures by Country

3.4.1 North America K Cells Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America K Cells Sales by Country (2019-2030)

3.4.3 North America K Cells Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe K Cells Market Facts & Figures by Country

3.5.1 Europe K Cells Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe K Cells Sales by Country (2019-2030)

3.5.3 Europe K Cells Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific K Cells Market Facts & Figures by Country

3.6.1 Asia Pacific K Cells Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific K Cells Sales by Country (2019-2030)

3.6.3 Asia Pacific K Cells Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America K Cells Market Facts & Figures by Country

3.7.1 Latin America K Cells Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America K Cells Sales by Country (2019-2030)

3.7.3 Latin America K Cells Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa K Cells Market Facts & Figures by Country

3.8.1 Middle East and Africa K Cells Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa K Cells Sales by Country (2019-2030)

3.8.3 Middle East and Africa K Cells Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global K Cells Sales by Type (2019-2030)

4.1.1 Global K Cells Sales by Type (2019-2024)

4.1.2 Global K Cells Sales by Type (2025-2030)

4.1.3 Global K Cells Sales Market Share by Type (2019-2030)

4.2 Global K Cells Revenue by Type (2019-2030)

4.2.1 Global K Cells Revenue by Type (2019-2024)

4.2.2 Global K Cells Revenue by Type (2025-2030)

4.2.3 Global K Cells Revenue Market Share by Type (2019-2030)

4.3 Global K Cells Price by Type (2019-2030)

5 Segment by Application

5.1 Global K Cells Sales by Application (2019-2030)

5.1.1 Global K Cells Sales by Application (2019-2024)

5.1.2 Global K Cells Sales by Application (2025-2030)

5.1.3 Global K Cells Sales Market Share by Application (2019-2030)

5.2 Global K Cells Revenue by Application (2019-2030)

5.2.1 Global K Cells Revenue by Application (2019-2024)

5.2.2 Global K Cells Revenue by Application (2025-2030)

5.2.3 Global K Cells Revenue Market Share by Application (2019-2030)

5.3 Global K Cells Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Chipscreen Biosciences

6.1.1 Chipscreen Biosciences Corporation Information

6.1.2 Chipscreen Biosciences Description and Business Overview

6.1.3 Chipscreen Biosciences K Cells Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Chipscreen Biosciences K Cells Product Portfolio

6.1.5 Chipscreen Biosciences Recent Developments/Updates

6.2 Affimed NV

6.2.1 Affimed NV Corporation Information

6.2.2 Affimed NV Description and Business Overview

6.2.3 Affimed NV K Cells Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Affimed NV K Cells Product Portfolio

6.2.5 Affimed NV Recent Developments/Updates

6.3 Altor BioScience

6.3.1 Altor BioScience Corporation Information

6.3.2 Altor BioScience Description and Business Overview

6.3.3 Altor BioScience K Cells Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Altor BioScience K Cells Product Portfolio

6.3.5 Altor BioScience Recent Developments/Updates

6.4 Innate Pharma

6.4.1 Innate Pharma Corporation Information

6.4.2 Innate Pharma Description and Business Overview

6.4.3 Innate Pharma K Cells Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Innate Pharma K Cells Product Portfolio

6.4.5 Innate Pharma Recent Developments/Updates

6.5 Takeda

6.5.1 Takeda Corporation Information

6.5.2 Takeda Description and Business Overview

6.5.3 Takeda K Cells Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Takeda K Cells Product Portfolio

6.5.5 Takeda Recent Developments/Updates

6.6 Sorrento Therapeutics

6.6.1 Sorrento Therapeutics Corporation Information

6.6.2 Sorrento Therapeutics Description and Business Overview

6.6.3 Sorrento Therapeutics K Cells Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Sorrento Therapeutics K Cells Product Portfolio

6.6.5 Sorrento Therapeutics Recent Developments/Updates

6.7 NantKwest

6.6.1 NantKwest Corporation Information

6.6.2 NantKwest Description and Business Overview

6.6.3 NantKwest K Cells Sales, Revenue and Gross Margin (2019-2024)

6.4.4 NantKwest K Cells Product Portfolio

6.7.5 NantKwest Recent Developments/Updates

6.8 Bristol-Myers Squibb

6.8.1 Bristol-Myers Squibb Corporation Information

6.8.2 Bristol-Myers Squibb Description and Business Overview

6.8.3 Bristol-Myers Squibb K Cells Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Bristol-Myers Squibb K Cells Product Portfolio

6.8.5 Bristol-Myers Squibb Recent Developments/Updates

6.9 NKT

6.9.1 NKT Corporation Information

6.9.2 NKT Description and Business Overview

6.9.3 NKT K Cells Sales, Revenue and Gross Margin (2019-2024)

6.9.4 NKT K Cells Product Portfolio

6.9.5 NKT Recent Developments/Updates

6.10 Henry Ford Health Services

6.10.1 Henry Ford Health Services Corporation Information

6.10.2 Henry Ford Health Services Description and Business Overview

6.10.3 Henry Ford Health Services K Cells Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Henry Ford Health Services K Cells Product Portfolio

6.10.5 Henry Ford Health Services Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 K Cells Industry Chain Analysis

7.2 K Cells Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 K Cells Production Mode & Process

7.4 K Cells Sales and Marketing

7.4.1 K Cells Sales Channels

7.4.2 K Cells Distributors

7.5 K Cells Customers

8 K Cells Market Dynamics

8.1 K Cells Industry Trends

8.2 K Cells Market Drivers

8.3 K Cells Market Challenges

8.4 K Cells Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Chipscreen Biosciences

Sorrento Therapeutics

NantKwest Inc

Bristol–Myers Squibb

NKT

Henry Ford Health Services

List of Tables

Table 1. Global K Cells Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global K Cells Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global K Cells Market Competitive Situation by Manufacturers in 2023

Table 4. Global K Cells Sales (g) of Key Manufacturers (2019-2024)

Table 5. Global K Cells Sales Market Share by Manufacturers (2019-2024)

Table 6. Global K Cells Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global K Cells Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market K Cells Average Price (USD/g) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of K Cells, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of K Cells, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of K Cells, Product Type & Application

Table 12. Global Key Manufacturers of K Cells, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global K Cells by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in K Cells as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global K Cells Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global K Cells Sales by Region (2019-2024) & (g)

Table 18. Global K Cells Sales Market Share by Region (2019-2024)

Table 19. Global K Cells Sales by Region (2025-2030) & (g)

Table 20. Global K Cells Sales Market Share by Region (2025-2030)

Table 21. Global K Cells Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global K Cells Revenue Market Share by Region (2019-2024)

Table 23. Global K Cells Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global K Cells Revenue Market Share by Region (2025-2030)

Table 25. North America K Cells Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America K Cells Sales by Country (2019-2024) & (g)

Table 27. North America K Cells Sales by Country (2025-2030) & (g)

Table 28. North America K Cells Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America K Cells Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe K Cells Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe K Cells Sales by Country (2019-2024) & (g)

Table 32. Europe K Cells Sales by Country (2025-2030) & (g)

Table 33. Europe K Cells Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe K Cells Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific K Cells Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific K Cells Sales by Region (2019-2024) & (g)

Table 37. Asia Pacific K Cells Sales by Region (2025-2030) & (g)

Table 38. Asia Pacific K Cells Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific K Cells Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America K Cells Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America K Cells Sales by Country (2019-2024) & (g)

Table 42. Latin America K Cells Sales by Country (2025-2030) & (g)

Table 43. Latin America K Cells Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America K Cells Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa K Cells Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa K Cells Sales by Country (2019-2024) & (g)

Table 47. Middle East & Africa K Cells Sales by Country (2025-2030) & (g)

Table 48. Middle East & Africa K Cells Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa K Cells Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global K Cells Sales (g) by Type (2019-2024)

Table 51. Global K Cells Sales (g) by Type (2025-2030)

Table 52. Global K Cells Sales Market Share by Type (2019-2024)

Table 53. Global K Cells Sales Market Share by Type (2025-2030)

Table 54. Global K Cells Revenue (US$ Million) by Type (2019-2024)

Table 55. Global K Cells Revenue (US$ Million) by Type (2025-2030)

Table 56. Global K Cells Revenue Market Share by Type (2019-2024)

Table 57. Global K Cells Revenue Market Share by Type (2025-2030)

Table 58. Global K Cells Price (USD/g) by Type (2019-2024)

Table 59. Global K Cells Price (USD/g) by Type (2025-2030)

Table 60. Global K Cells Sales (g) by Application (2019-2024)

Table 61. Global K Cells Sales (g) by Application (2025-2030)

Table 62. Global K Cells Sales Market Share by Application (2019-2024)

Table 63. Global K Cells Sales Market Share by Application (2025-2030)

Table 64. Global K Cells Revenue (US$ Million) by Application (2019-2024)

Table 65. Global K Cells Revenue (US$ Million) by Application (2025-2030)

Table 66. Global K Cells Revenue Market Share by Application (2019-2024)

Table 67. Global K Cells Revenue Market Share by Application (2025-2030)

Table 68. Global K Cells Price (USD/g) by Application (2019-2024)

Table 69. Global K Cells Price (USD/g) by Application (2025-2030)

Table 70. Chipscreen Biosciences Corporation Information

Table 71. Chipscreen Biosciences Description and Business Overview

Table 72. Chipscreen Biosciences K Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)

Table 73. Chipscreen Biosciences K Cells Product

Table 74. Chipscreen Biosciences Recent Developments/Updates

Table 75. Affimed NV Corporation Information

Table 76. Affimed NV Description and Business Overview

Table 77. Affimed NV K Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)

Table 78. Affimed NV K Cells Product

Table 79. Affimed NV Recent Developments/Updates

Table 80. Altor BioScience Corporation Information

Table 81. Altor BioScience Description and Business Overview

Table 82. Altor BioScience K Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)

Table 83. Altor BioScience K Cells Product

Table 84. Altor BioScience Recent Developments/Updates

Table 85. Innate Pharma Corporation Information

Table 86. Innate Pharma Description and Business Overview

Table 87. Innate Pharma K Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)

Table 88. Innate Pharma K Cells Product

Table 89. Innate Pharma Recent Developments/Updates

Table 90. Takeda Corporation Information

Table 91. Takeda Description and Business Overview

Table 92. Takeda K Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)

Table 93. Takeda K Cells Product

Table 94. Takeda Recent Developments/Updates

Table 95. Sorrento Therapeutics Corporation Information

Table 96. Sorrento Therapeutics Description and Business Overview

Table 97. Sorrento Therapeutics K Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)

Table 98. Sorrento Therapeutics K Cells Product

Table 99. Sorrento Therapeutics Recent Developments/Updates

Table 100. NantKwest Corporation Information

Table 101. NantKwest Description and Business Overview

Table 102. NantKwest K Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)

Table 103. NantKwest K Cells Product

Table 104. NantKwest Recent Developments/Updates

Table 105. Bristol-Myers Squibb Corporation Information

Table 106. Bristol-Myers Squibb Description and Business Overview

Table 107. Bristol-Myers Squibb K Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)

Table 108. Bristol-Myers Squibb K Cells Product

Table 109. Bristol-Myers Squibb Recent Developments/Updates

Table 110. NKT Corporation Information

Table 111. NKT Description and Business Overview

Table 112. NKT K Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)

Table 113. NKT K Cells Product

Table 114. NKT Recent Developments/Updates

Table 115. Henry Ford Health Services Corporation Information

Table 116. Henry Ford Health Services Description and Business Overview

Table 117. Henry Ford Health Services K Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)

Table 118. Henry Ford Health Services K Cells Product

Table 119. Henry Ford Health Services Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. K Cells Distributors List

Table 123. K Cells Customers List

Table 124. K Cells Market Trends

Table 125. K Cells Market Drivers

Table 126. K Cells Market Challenges

Table 127. K Cells Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of K Cells

Figure 2. Global K Cells Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global K Cells Market Share by Type in 2023 & 2030

Figure 4. Mogamulizumab Product Picture

Figure 5. Lorvotuzumab Mertansine Product Picture

Figure 6. Others Product Picture

Figure 7. Global K Cells Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global K Cells Market Share by Application in 2023 & 2030

Figure 9. Cancer

Figure 10. Cardiovascular Diseases

Figure 11. Others

Figure 12. Global K Cells Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global K Cells Market Size (2019-2030) & (US$ Million)

Figure 14. Global K Cells Sales (2019-2030) & (g)

Figure 15. Global K Cells Average Price (USD/g) & (2019-2030)

Figure 16. K Cells Report Years Considered

Figure 17. K Cells Sales Share by Manufacturers in 2023

Figure 18. Global K Cells Revenue Share by Manufacturers in 2023

Figure 19. The Global 5 and 10 Largest K Cells Players: Market Share by Revenue in 2023

Figure 20. K Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 21. Global K Cells Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 22. North America K Cells Sales Market Share by Country (2019-2030)

Figure 23. North America K Cells Revenue Market Share by Country (2019-2030)

Figure 24. U.S. K Cells Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Canada K Cells Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Europe K Cells Sales Market Share by Country (2019-2030)

Figure 27. Europe K Cells Revenue Market Share by Country (2019-2030)

Figure 28. Germany K Cells Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. France K Cells Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. U.K. K Cells Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Italy K Cells Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Russia K Cells Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Asia Pacific K Cells Sales Market Share by Region (2019-2030)

Figure 34. Asia Pacific K Cells Revenue Market Share by Region (2019-2030)

Figure 35. China K Cells Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Japan K Cells Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. South Korea K Cells Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. India K Cells Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Australia K Cells Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Taiwan K Cells Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Indonesia K Cells Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Thailand K Cells Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Malaysia K Cells Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Philippines K Cells Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Latin America K Cells Sales Market Share by Country (2019-2030)

Figure 46. Latin America K Cells Revenue Market Share by Country (2019-2030)

Figure 47. Mexico K Cells Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Brazil K Cells Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Argentina K Cells Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Middle East & Africa K Cells Sales Market Share by Country (2019-2030)

Figure 51. Middle East & Africa K Cells Revenue Market Share by Country (2019-2030)

Figure 52. Turkey K Cells Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia K Cells Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. U.A.E K Cells Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Global Sales Market Share of K Cells by Type (2019-2030)

Figure 56. Global Revenue Market Share of K Cells by Type (2019-2030)

Figure 57. Global K Cells Price (USD/g) by Type (2019-2030)

Figure 58. Global Sales Market Share of K Cells by Application (2019-2030)

Figure 59. Global Revenue Market Share of K Cells by Application (2019-2030)

Figure 60. Global K Cells Price (USD/g) by Application (2019-2030)

Figure 61. K Cells Value Chain

Figure 62. K Cells Production Process

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Distributors Profiles

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Molecular Quality Controls Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-4P1358

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Ozone Therapy in Dermatology Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-1O14324

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Ankle Replacement System Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-36H5857

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Pharyngeal Cancer Therapeutics Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-9E14435

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions